Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sun, Jin"'
Autor:
Vittorio Rizzoli, Lori A. Ehrlich, Sun Jin Choi, Simona Colla, Irene M. Ghobrial, G. David Roodman, Francesca Morandi, Ho Yeon Chung, Nicola Giuliani
Publikováno v:
Blood. 106:1407-1414
Bone destruction in multiple myeloma is characterized both by markedly increased osteoclastic bone destruction and severely impaired osteoblast activity. We reported that interleukin-3 (IL-3) levels are increased in bone marrow plasma of myeloma pati
Autor:
Melissa Alsina, Sun Jin Choi, Rowena D. Devlin, Jose C. Cruz, Hoyeon Chung, G. David Roodman, Fiona E. Craig
Publikováno v:
Blood. 96:671-675
This study was designed to determine if macrophage inhibitory protein-1 alpha (MIP-1 alpha), a recently described osteoclast (OCL) stimulatory factor,(1) was present in marrow from patients with multiple myeloma (MM) and possibly involved in the bone
Autor:
Seung-Hyun Nam, Won Seog Kim, Sun Jin Sym, Ho Young Kim, Hyeon Seok Eom, Hye Jin Kang, Cheolwon Suh, Seok Jin Kim
Publikováno v:
Blood. 110:3446-3446
Etoposide (E), methylprednisolone (S), high-dose cytarabine (HA), and cisplatin (P) (ESHAP) combination is commonly used salvage regimen for non-Hodgkin’s lymphoma (NHL). Oxaliplatin (Ox), a new platinum derivative, showed substantially different c
Autor:
Sang-We Kim, Sun Jin Sym, S. Lee, Jae-Cheol Jo, Dae Ho Lee, Cheolwon Suh, Byung Wook Kang, Geundoo Jang
Publikováno v:
Blood. 110:5094-5094
High-dose chemotherapy supported by autologous stem cell transplantation (ASCT) after the combined chemotherapy with vincristine, doxorubicin and dexamethasone (VAD) is an effective therapy for newly diagnosed, multiple myeloma. Bolus vincristine/dox
Autor:
Geundoo Jang, Cheolwon Suh, Sun-Jin Sym, Sang We Kim, Dae Ho Lee, Jooryung Huh, Shin Kim, Won Seog Kim
Publikováno v:
Blood. 110:4446-4446
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin’s lymphoma. Recently, with new treatment strategies including the addition of rituximab to CHOP and dose-dense CHOP therapy there has been much progress in the treatment for these
Autor:
Chang-Ki Min, Cheolwon Suh, Sun Jin Sym, Kihyun Kim, Jae Yong Kwak, Jong Ho Won, Seung-Tae Lee
Publikováno v:
Blood. 110:5132-5132
High-dose therapy with autologous stem cell transplantation (ASCT) is now considered the standard of care in patients with multiple myeloma (MM). This retrospective case analysis evaluated the prognostic influence of pre-transplant characteristics, t
Autor:
Dae Ho Lee, Joo Ryung Huh, Cheolwon Suh, Min Kyoung Kim, Seongsoo Jang, Sang We Kim, Sun Jin Sym, Hyun Sook Chi, Seong Sook Lee, Shin Kim, Chan Jeong Park
Publikováno v:
Blood. 108:5443-5443
Objectives: The mobilization chemotherapy should be directed toward the dual objectives of good antilymphoma activity and adequate PBSC mobilization. Previously, we reported the ESHAP plus G-CSF is an effective mobilization regimen in patients with r
Publikováno v:
Blood. 108:4631-4631
The cell proliferation rate of tumors from patients with non-Hodgkin’s lymphomas has been shown to correlate with survival in previous studies. The aim of this study was to evaluate the independent prognostic value of Ki-67 expression level and the
Autor:
Joo Ryung Huh, Seongsoo Jang, Min Kyoung Kim, Sang We Kim, Chan Jeong Park, Sun Jin Sym, Shin Kim, Dae Ho Lee, Cheolwon Suh, Hyun Sook Chi, Seoung Sook Lee
Publikováno v:
Blood. 108:4682-4682
Objectives: Although CHOP-type chemotherapy has been the mainstay of therapy, outcome of PTCL has been uniformly disappointing. Despite the poor outcome after conventional chemotherapy, the impact of high-dose chemotherapy (HDCT) and ASCT is not well